Market Place
Sourcing Support
GUERBET : Financial agenda for 2025
31 Oct 2024 //
GLOBENEWSWIRE
GUERBET : Revenue at September 30, 2024.
24 Oct 2024 //
GLOBENEWSWIRE
GUERBET : H1 2024 results.
25 Sep 2024 //
GLOBENEWSWIRE
GUERBET : H1 2024 revenue.
25 Jul 2024 //
GLOBENEWSWIRE
Guerbet : Hugues Lecat appointed Chairman of the Board of Directors of Guerbet.
24 May 2024 //
GLOBENEWSWIRE
NUCLIDIUM, Guerbet Partner On Targeted Copper Radiotheranostics
22 May 2024 //
GLOBENEWSWIRE
Guerbet : Q1 2024 revenue.
25 Apr 2024 //
GLOBENEWSWIRE
Guerbet: Financial agenda for 2024
15 Jan 2024 //
GLOBENEWSWIRE
Guerbet to Spotlight Diagnostic and Interventional Solutions at the 2023 RSNA
02 Nov 2023 //
PR NEWSWIRE
GUERBET : Revenue at 30 September 2023.
19 Oct 2023 //
GLOBENEWSWIRE
Guerbet: CHMP positive opinion
12 Oct 2023 //
GLOBENEWSWIRE
Guerbet: 2023 half-year results
20 Sep 2023 //
GLOBENEWSWIRE
Guerbet: First-half 2023 revenue
20 Jul 2023 //
GLOBENEWSWIRE
Guerbet: Guerbet wins PI-CAI Grand Challenge on detection of prostate cancer
17 Jul 2023 //
GLOBENEWSWIRE
Guerbet strengthens its Executive Committee with two new appointments
10 Jul 2023 //
GLOBENEWSWIRE
Guerbet: Changes in Guerbet`s Board of Directors
26 May 2023 //
GLOBENEWSWIRE
Guerbet Announces ACR Committee on Drugs and Contrast Media Classifies Elucirem
09 May 2023 //
PR NEWSWIRE
Guerbet: Q1 2023 Revenue
20 Apr 2023 //
GLOBENEWSWIRE
Guerbet: 2022 annual results
22 Mar 2023 //
GLOBENEWSWIRE
Guerbet Announces Commercial Launch & First Patient Dosing of Elucirem Injection
13 Feb 2023 //
PR NEWSWIRE
Guerbet: 2022 revenue
09 Feb 2023 //
GLOBENEWSWIRE
Guerbet Releases First Production Batch of Elucirem Injection
02 Feb 2023 //
PR NEWSWIRE
Guerbet: 2023 Strategic Priorities
16 Jan 2023 //
GLOBENEWSWIRE
Guerbet: Intrasense opens its share capital to the Guerbet Group
11 Jan 2023 //
GLOBENEWSWIRE
Guerbet: Revenue at September 30, 2022
20 Oct 2022 //
GLOBENEWSWIRE
Guerbet announces U.S. (FDA) approval of Elucirem™ (Gadopiclenol)
21 Sep 2022 //
GLOBENEWSWIRE
Guerbet Announces U.S. FDA Approval of Elucirem Injection
21 Sep 2022 //
PRNEWSWIRE
Guerbet receives EMA acceptance of EluciremTM as the Brand Name for Gadopiclenol
13 Jun 2022 //
GLOBENEWSWIRE
Guerbet strengthens its Executive Committee, appoints C. Bamire, General Counsel
06 Apr 2022 //
GLOBENEWSWIRE
Gadopiclenol MA dossier submissions accepted for review by EMA and FDA
29 Mar 2022 //
GLOBENEWSWIRE
Guerbet: 2021 annual results
23 Mar 2022 //
GLOBENEWSWIRE
Guerbet expands portfolio with microcatheters and guidewires
07 Mar 2022 //
PRNEWSWIRE
Guerbet expands portfolio with microcatheters and guidewires
07 Mar 2022 //
GLOBENEWSWIRE
Guerbet Appoints Jared Houk as Commercial VP for North America
12 Jan 2022 //
PRNEWSWIRE
Guerbet & Bracco Imaging Announce a Global Strategic Collab for Gadopiclenol
14 Dec 2021 //
GLOBENEWSWIRE
Guerbet, Bracco Imaging Collaborate for Gadopiclenol
14 Dec 2021 //
PRNEWSWIRE
Guerbet: Revenue at June 30, 2021
22 Jul 2021 //
GLOBENEWSWIRE
Guerbet: Revenue at June 30, 2021
22 Jul 2021 //
GLOBENEWSWIRE
Guerbet to pay $23.7m for Accurate Medical Therapeutics
15 Jan 2018 //
MASSDEVICES
Mallinckrodt Divests Contrast Media Biz to Guerbet For $270 Million
28 Jul 2015 //
BIOSPACE
